Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Apr;30(4):801–805. doi: 10.1128/jcm.30.4.801-805.1992

Reactivity patterns and infection status of serum samples with indeterminate Western immunoblot tests for antibody to human immunodeficiency virus type 1.

E Ramirez 1, P Uribe 1, D Escanilla 1, G Sanchez 1, R T Espejo 1
PMCID: PMC265165  PMID: 1572966

Abstract

Serum samples with indeterminate Western blot (WB) tests from 61 individuals whose sera were positive by enzyme-linked immunosorbent assay (ELISA) were studied in order to characterize their putative reactions with the human immunodeficiency virus (HIV) proteins and to resolve the HIV infection status of these individuals. The reaction observed by WB could not be confirmed either by radioimmunoprecipitation assay and subsequent electrophoresis (RIPA) or by use of LiaTek (Organon Teknika, Turnbout, The Netherlands) in 28% of the samples. Of the 86 samples that were indeterminate by WB, 66 reacted with p24 by WB; this reaction was confirmed by RIPA in only 21 (32%) and by LiaTek in 49 (74%) of the 66 samples. On the other hand, none of the indeterminate samples that reacted with HIV envelope proteins by WB did so by LiaTek, while 50% precipitated at least some of these proteins in the RIPA. The sensitivities of the three methods for detecting the antibody reaction with the different HIV proteins, which were studied with serial dilutions of positive serum samples, were similar. Thus, a lower sensitivity of RIPA or LiaTek does not seem to be the cause for the lack of reaction of the WB-indeterminate samples by these two methods. Sequential samples from individuals whose serum samples reacted by the three methods gave reproducible results, but all showed low antibody titers. Peripheral blood mononuclear cells obtained from three of the four individuals with sequential samples that reacted with HIV env proteins by WB and RIPA were negative for HIV provirus DNA after amplification by the polymerase chain reaction.

Full text

PDF
801

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott M. A., Poiesz B. J., Byrne B. C., Kwok S., Sninsky J. J., Ehrlich G. D. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis. 1988 Dec;158(6):1158–1169. doi: 10.1093/infdis/158.6.1158. [DOI] [PubMed] [Google Scholar]
  2. Blomberg J., Vincic E., Jönsson C., Medstrand P., Pipkorn R. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1363–1372. doi: 10.1089/aid.1990.6.1363. [DOI] [PubMed] [Google Scholar]
  3. Delaporte E., Dupont A., Merlin M., Josse R., Hamono B., Larouze B., Brun-Vezinet F. Seroepidemiological survey of HIV-1 and HIV-2 antibodies in Gabon. AIDS. 1988 Apr;2(2):136–137. [PubMed] [Google Scholar]
  4. Espejo R. T., Uribe P. Immunoprecipitation of human immunodeficiency virus type 2 glycoproteins by sera positive for human immunodeficiency virus type 1. J Clin Microbiol. 1990 Sep;28(9):2107–2110. doi: 10.1128/jcm.28.9.2107-2110.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Genesca J., Shih J. W., Jett B. W., Hewlett I. K., Epstein J. S., Alter H. J. What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet. 1989 Oct 28;2(8670):1023–1025. doi: 10.1016/s0140-6736(89)91027-1. [DOI] [PubMed] [Google Scholar]
  6. Herring A. J., Inglis N. F., Ojeh C. K., Snodgrass D. R., Menzies J. D. Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol. 1982 Sep;16(3):473–477. doi: 10.1128/jcm.16.3.473-477.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Huet T., Dazza M. C., Brun-Vézinet F., Roelants G. E., Wain-Hobson S. A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot. AIDS. 1989 Nov;3(11):707–715. doi: 10.1097/00002030-198911000-00004. [DOI] [PubMed] [Google Scholar]
  8. Jackson J. B., MacDonald K. L., Cadwell J., Sullivan C., Kline W. E., Hanson M., Sannerud K. J., Stramer S. L., Fildes N. J., Kwok S. Y. Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1. N Engl J Med. 1990 Jan 25;322(4):217–222. doi: 10.1056/NEJM199001253220402. [DOI] [PubMed] [Google Scholar]
  9. Josephson S. L., Swack N. S., Ramirez M. T., Hausler W. J., Jr Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type. J Clin Microbiol. 1989 May;27(5):932–937. doi: 10.1128/jcm.27.5.932-937.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kleinman S., Fitzpatrick L., Secord K., Wilke D. Follow-up testing and notification of anti-HIV Western blot atypical (indeterminant) donors. Transfusion. 1988 May-Jun;28(3):280–282. doi: 10.1046/j.1537-2995.1988.28388219161.x. [DOI] [PubMed] [Google Scholar]
  11. Lefrère J. J., Couroucé A. M., Lucotte G., Boitard C., Kaplan C., Nicolas J. C., Bricout F., Lambin P., Doinel C., Muller J. Y. Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS. 1988 Aug;2(4):287–290. doi: 10.1097/00002030-198808000-00008. [DOI] [PubMed] [Google Scholar]
  12. MacDonald K. L., Jackson J. B., Bowman R. J., Polesky H. F., Rhame F. S., Balfour H. H., Jr, Osterholm M. T. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med. 1989 Apr 15;110(8):617–621. doi: 10.7326/0003-4819-110-8-617. [DOI] [PubMed] [Google Scholar]
  13. Mariotti M., Lefrère J. J., Noel B., Ferrer-Le-Coeur F., Vittecoq D., Girot R., Bosser C., Couroucé A. M., Salmon C., Rouger P. DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals. AIDS. 1990 Jul;4(7):633–637. doi: 10.1097/00002030-199007000-00004. [DOI] [PubMed] [Google Scholar]
  14. Mohammed I., Nasidi A., Chikwem J. O., Williams E. E., Harry T. O., Okafor G. O., Ajose-Coker O. O., Ademiluyi S. A., Tukei P., De Cock K. M. HIV infection in Nigeria. AIDS. 1988 Feb;2(1):61–62. [PubMed] [Google Scholar]
  15. Simmonds P., Balfe P., Peutherer J. F., Ludlam C. A., Bishop J. O., Brown A. J. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol. 1990 Feb;64(2):864–872. doi: 10.1128/jvi.64.2.864-872.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tribe D. E., Reed D. L., Lindell P., Kenealy W. R., Ferguson B. Q., Cybulski R., Winslow D., Waselefsky D. M., Petteway S. R., Jr Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population. J Clin Microbiol. 1988 Apr;26(4):641–647. doi: 10.1128/jcm.26.4.641-647.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Van de Perre P., Nzaramba D., Allen S., Riggin C. H., Sprecher-Goldberger S., Butzler J. P. Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. J Clin Microbiol. 1988 Mar;26(3):552–556. doi: 10.1128/jcm.26.3.552-556.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES